Understanding how H2A.Z regulates early embryo development
Regulation and function of H2A.Z during the mid-blastula transition
This study is looking at how a special protein called H2A.Z helps control the timing of early embryo development in zebrafish and fruit flies, which could help us understand how genes turn on and off during this important stage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11057607 on NIH RePORTER |
What this research studies
This research investigates the role of the histone variant H2A.Z during a critical phase of early embryo development known as the mid-blastula transition (MBT). By using model organisms like zebrafish and fruit flies, the study aims to uncover how changes in H2A.Z levels affect gene activation and developmental timing. The researchers will employ genomics techniques and gene expression analysis to explore the mechanisms behind these processes, focusing on how H2A.Z is incorporated into chromatin and its impact on embryonic development.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with a keen interest in developmental biology or those affected by genetic conditions related to early embryonic development.
Not a fit: Patients with fully developed conditions unrelated to embryonic development or those not interested in the biological mechanisms of early development may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a better understanding of developmental disorders and inform strategies for improving embryo viability in various species.
How similar studies have performed: Previous research has shown that understanding histone regulation in model organisms can provide insights into developmental processes, suggesting that this approach has potential for success.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Welte, Michael Andreas — University of Rochester
- Study coordinator: Welte, Michael Andreas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.